Xolair 75 MG/0.5 ML syringe 0.5ML

Ended Awarded

Contract number
SPE2DB24FSU79
Awardee
Awarding agency
Obligated
$7,737

Award facts

Contract value 100% obligated
$7,737.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
424210 Drugs and Druggists' Sundries Merchant Wholesalers
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Park Ridge, IL 60068, USA

Award details come from SAM.gov/FPDS.

About this award

DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at $7,737 by the Defense Logistics Agency to provide 4562627000 units of Xolair 75 MG/0.5 ML syringes. This delivery order was issued against DMS Pharmaceutical Group's indefinite delivery contract with the Defense Logistics Agency to supply pharmaceutical and medical products with a total potential value of up to $5 million through December 2025. No set-aside designation was used for this award. DMS Pharmaceutical Group will deliver the Xolair syringes to support military treatment facilities operated by the Defense Logistics Agency.

Quick answers

Who was awarded contract SPE2DB24FSU79?

SPE2DB24FSU79 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on October 25, 2023.

How much is contract SPE2DB24FSU79 worth?

The government has obligated $7,737 on SPE2DB24FSU79.

Is contract SPE2DB24FSU79 an order under another contract?

Yes. SPE2DB24FSU79 is a delivery order under SPE2DB22D9367, an indefinite delivery contract.

Was contract SPE2DB24FSU79 competed?

The extent of competition for SPE2DB24FSU79 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award